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ABSTRACT

A COMPARISON OF GENETIC MICROARRAY ANALYSES:
A MIXED MODELS APPROACH VERSUS THE
SIGNIFICANCE ANALYSIS OF MICROARRAYS

Nathan W. Stephens
Department of Statistics
Master of Science

DNA microarrays are a relatively new technology for assessing the expression
levels of thousands of genes simultaneously. Researchers hope to find genes that are
differentially expressed by hybridizing cDNA from known treatment sources with various genes spotted on the microarrays. The large number of tests involved in analyzing
microarrays has raised new questions in multiple testing. Several approaches for identifying differentially expressed genes have been proposed. This paper considers two:
(1) a mixed models approach, and (2) the Significance Analysis of Microarrays.
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Chapter 1
Introduction
Genomics, the study of genes and their functions, generates huge quantities of
data. A common question in the analysis of genetic data is the identification of differentially expressed genes. Differentially expressed genes are those whose expression
levels are associated with a response or covariate of interest. DNA microarrays can be
used to simultaneously test thousands of genes. This has raised new interest in multiple testing procedures. The objective in many statistical analyses is to identify many
differentially-expressed significant genes while incurring a relatively low proportion of
false positives.
One popular approach to analyzing microarray data is the mixed models approach developed by Wolfinger et al. (2001). This method uses linear mixed models
to normalize and analyze data. The normalization model attempts to remove experimental effects that are common across all genes. The residuals from the normalization
model are then passed to separate gene models. Each gene is modeled with a separate gene model, resulting in as many models as there are genes. All possible pairwise
treatment comparisons are tested for significance. Significant genes are those with
significant pairwise treatment comparisons. A Bonferroni correction is used to control
for the family-wise error rate.

1

Another popular approach to analyzing microarray data is the The Significance Analysis of Microarrays (SAM) developed by Tusher et al. (2001). The SAM
procedure involves computing a relative difference for each gene and then comparing
it to its expected value. The expected value is calculated using a resampling technique. Genes with relative differences that fall outside tolerance limits are declared
significant. The SAM procedure also estimates the False Discovery Rate (FDR),
which is the proportion of null genes among those called significant; the Miss Rate
(MR), which is the proportion of significant genes among those called non-significant;
and the Tail Strength (TS) which is an overall measure of significance for a set of
hypothesis tests.
This project compares the mixed models approach developed by Wolfinger
et al. (2001) to the SAM procedure developed by Tusher et al. (2001). Genetic microarray data gathered by the University of Utah are used to make the comparison.
Causes for the differences between results are discussed, an attempt is made to correct two of the causes, and inherent and flexible characteristics of both methods are
discussed.

2

Chapter 2
Literature Review
The development and use of DNA microarrays is a relatively new technology
for measuring gene expression. A DNA microarray is a large set of cloned DNA
molecules spotted onto a solid matrix (such as a microscope slide) for use in probing
a biological sample to determine gene expression. Each spot on a microarray contains
thousands of samples of a particular isolated area, or genes of single strand DNA.
Microarray gene spots are not printed simultaneously; they are printed in
blocks called print-tip groups. Microarrays tend to have a few dozen print-tip groups.
All the genes in a single print-tip group are printed simultaneously using the same
print-tip. Therefore, print-tip effects tend to be an important source of systematic
variability. Correcting for the variability due to print-tips is often an important part
of analyzing microarray data.
Microarrays allow researchers to simultaneously test thousands of genes. In
order to test the genes on a two-channel microarray experiment, a sample of DNA
is taken from a treatment specimen and a sample of DNA is taken from a control
specimen. The DNA from the treatment and the control is split into single strand
molecules (cDNA) that can combine or hybridize with genes on the microarray. In
a two-channel microarray experiment, the cDNA is tagged with florescent dyes for

3

identification purposes. It is common to use green and red dyes to identify the
treatment and control strands.
Both samples from the treatment and the control are then applied to the
microarray. The single strand samples from the specimens attempt to bind with the
single strand genes on the spotted microarray. The amount of binding between the
spots and the samples is a measurement of gene expression. Spots that have heavy
binding to the treatment look green under a green laser, whereas spots that have
heavy binding to the control look red under a red laser. The measurements collected
under the two lasers are called gene intensities.
Scanning software produces foreground images and background images for each
dye. The background image represents the baseline value for the gene expression. In
nearly all microarray analysis it is common to subtract the background image from
the foreground image, creating background corrected gene intensities.
Researchers use gene intensities to quantify gene expression. If R is the measurement of gene expression for the treatment (assume it is labelled with a red dye),
and G is the measurement of gene expression for the control (assume it is labelled
with a green dye), then a common measurement for the overall gene expression is
M = log2 (R/G). The value M is called the log ratio and it represents the difference between the treatment and the control. Another common measurement for the
overall gene expression is A = log2

√

RG. This measurement is the log average and

represents the average gene expression. Both M and A-values are common metrics
in many two-channel microarray experiments.

4

2.1

Normalization
Microarray data tend to be very noisy. Some sources of variation include dye

effects from the red and green dyes applied to the cDNA strands, print quality effects
due to the gene printing on the microarray, scanning error, differing experimental
conditions, and spatial effects because the measurements come from a physical slide
(Yang et al., 2002). Before testing for differentially expressed genes, microarray data
must be normalized. (Note: some researchers such as Huber et al. (2002) prefer the
term calibrated.) The purpose of normalization is to adjust for effects that are due
to the noise of the experimental setup rather than effects that are due to genetic
differences (Smyth and Speed, 2003).
Correcting expression values for the background is typically the first step in
normalizing the data. The background corrected expression value is the foreground
expression value minus the background expression value. Negative or zero expression
values are problematic if logged data or log ratio data are sought. Huber et al.
(2002) suggests four methods for dealing with negative expression data: (1) ignore
the background estimates, (2) replace the negative estimates by 1 before taking the
logarithm, (3) subtract the 5%-quantile, then replace the remaining negative values by
1, and (4) flag them as missing. Smyth and Speed (2003) and Wolfinger et al. (2001)
recommend treating negative expression data as missing. Alternatively, expression
values can be transformed using a rank transformation or an arsinh transformation
(Huber et al., 2002).

5

Additional normalization often takes place on the background corrected log
ratios. The is the approach suggested by Dudoit et al. (2002), Smyth and Speed
(2003), and Yang et al. (2002). However, some approaches attempt to normalize the
background corrected log2 intensities. This latter approach is suggested by Huber
et al. (2002) and Wolfinger et al. (2001).
Normalization can be applied within a microarray and/or between microarrays.
The utility of normalizing between arrays in an experiment has been disputed. Smyth
and Speed (2003) suggest scaling the M -values so that each array has the same median
absolute deviation (MAD). However, normalizing between arrays can introduce more
variability in the data than it resolves. Yang et al. (2002) suggest foregoing betweenarray normalization in cases where the scale differences are small.
Several techniques have been proposed for normalizing gene intensities within
a microarray. Plots of the M -values versus the A-values (M A-plots) are useful in
evaluating intensity-dependent biases within arrays. It common for the M -values and
the A-values to be strongly correlated. Yang et al. (2002) and Smyth and Speed (2003)
suggest fitting lowess curves to M A-plots for each print-tip group. The residuals are
called the normalized log ratios and are calculated as → log2 R/G − ci (A), where
ci (A) is the lowess fit to the M A-plot for the ith print-tip group. This method has
the advantage of correcting both the intensity-dependent bias and spatial effects that
are associated with print-tip groups.
There are several different varieties of lowess normalization (Yang et al., 2002;
Smyth and Speed, 2003). For example, if there does not appear to be any difference between print-tip groups, then a global lowess normalization is appropriate. A
6

global lowess normalization takes place at the microarray level instead of the printtip group level. If there are peculiar spatial effects beyond those associated with
print-tip groups, then a two-dimensional lowess normalization is appropriate. The
two-dimensional technique uses a lowess surface to fit spatial effects. Smyth and
Speed (2003) point out that this method requires more investigation. If the data are
especially noisy, then normalizing with respect to the median is appropriate (Smyth
and Speed, 2003). Furthermore, composite lowess normalization can be used in conjunction with a known control group. Print-order normalization can be used to correct
for substantial print order effects. Finally, spot quality weights can be used to refine
the normalization process (Smyth and Speed, 2003).
Huber et al. (2002) take a different approach to normalizing data. They propose a transformation in which the variance of gene intensities becomes independent
of the mean. The transformation is of the form h(x) = arsinh(a + bx), where a and
b are tuning parameters. The proposed transformation produces difference statistics
(∆h) that may be viewed as a generalization of the log-ratio of two-channel microarray data. The variance of these difference statistics is approximately constant along
the whole intensity range. The transformation, which is applied globally, does not
adjust for spatial effects.
Tusher et al. (2001) compare the log average intensity for each hybridization
to a reference. The reference is calculated by taking the log average of the intensities
across all hybridizations. A linear least squares regression is fit to the cube root of
both the hybridization and reference log averages. The cube root is used because it
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allows negative values to be included. The normalized values are the residuals from
the linear least squares fit.
Wolfinger et al. (2001) fit the background corrected log2 intensities to a mixed
model, then use the residuals as normalized values. The model that normalizes the
data is called the normalization model and does not include any effects due to the
individual genes. The model includes fixed effects due to the treatments, and random
effects due to the arrays. The normalization model assumes that the random effects
are distributed normally with constant variance.
Finally, normalization should be accompanied by plots of the data. Smyth and
Speed (2003) suggest four visualization techniques. First, they use an M A-plot to
assess the relationship between dye-bias and intensity. They also recommend adding
a trend line to the plot to better assess the relationship. Second, they plot intensities
on a row and column grid called an image plot to assess spatial effects in the data.
They particularly recommend spatial plots of the background intensities and nonnormalized M -values. Third, they use side-by-side box plots of the M -values for each
print-tip group in order to visualize print-tip effects. Finally, they use an M A-plot
by print-tip to assess the relationship between intensities and print-tip effects.

2.2

Analysis Methods
After microarray data have been normalized, they can be analyzed to identify

differential gene expression. Several methods have been proposed. The following
section examines a mixed models approach, the Significance Analysis of Microarrays,
and a few other techniques.
8

2.2.1

Mixed Models Approach
Wolfinger et al. (2001) propose a mixed models approach to microarray anal-

ysis. This approach involves a normalization model and a gene model. Both models
use background corrected log2 intensities as opposed to log ratios or log averages.
There is a separate treatment and reference measurement for each spot on the array.
The reference is considered to be another treatment level, allowing the researcher
to measure the effect of the reference sample. The structure of the two models depends on the experimental setup and the discretion of the researcher; for example,
the researcher can include array effects, print-tip effects, or blocking effects in the
models. The normalization model attempts to remove experimental variability not
due to gene variability. The residuals from the normalization model are then used in
the gene model, which determines the significance of the gene. One gene model is fit
for every unique gene.
In the mixed models approach, genes are declared significant if their corresponding gene models contain significant treatment effects. If there are multiple
treatment levels, Wolfinger et al. (2001) recommend testing all pairwise comparisons
between the treatment levels. The most significant pairwise comparisons identify significant genes. A Bonferroni correction is used to control the family-wise error rate
(FWER).
Wolfinger et al. (2001) demonstrate the mixed models approach by analyzing
a publicly available two-channel microarray data set. The data include five treatment
µ ¶
5
levels. There are
= 10 pairwise comparisons for each of the 6,917 genes for a
2
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total of 69,170 tests. A Bonferroni correction is then used to control the FWER at
5%. For some studies the Bonferroni correction can be too conservative, yielding no
significant genes. Dudoit et al. (2003) suggest using adjusted p-values instead of a
Bonferroni correction.
The genes in the mixed models approach are modeled with independent errors.
Assuming heterogeneity among gene variances is reasonable; however, the residuals
from the normalization model are correlated by construction. Wolfinger et al. (2001)
argue that this concern makes little to no difference in practice. The effects fitted by
by the normalization and gene models are orthogonal. Furthermore, the effects in the
normalization model are estimated with such great precision that they are practically
constants.
The mixed models approach also assumes that the error terms for both the
normalization model and the gene models are normally distributed. Wolfinger et al.
(2001) recommend performing standard graphical and statistical checks of the residuals from the gene models.

2.2.2

Significance Analysis of Microarrays
Tusher et al. (2001) propose the Significance Analysis of Microarrays (SAM).

In the SAM procedure, effect differences are estimated with a statistic called the relative difference. The definition of the relative difference depends on the experimental
setup. For example, the relative difference for an experiment with two treatments
can be defined as a two-sample t-statistic. For more complicated designs the relative
difference can be defined as the researcher sees fit.
10

The relative differences are calculated for each gene and then ordered. The
expected value of the order statistics is calculated by bootstrapping, a technique for
assessing statistical accuracy (Good, 2001; Hastie et al., 2001). The order statistics
are then compared to their expected values. The order statistics that fall outside the
user-defined threshold are called significant. The user defines the threshold based on
estimates of the False Discovery Rate (FDR).
One concern for detecting differentially expressed genes is whether or not the
sample size is sufficient. Tibshirani (2005) suggests a method for assessing the sample
size based off of the FDR and the False Negative Rate (FNR). The user can then get
an idea of the power of the current experiment and the number of samples to prepare
for future experiments.
The SAM procedure itself does not normalize the data, and Tusher et al. (2001)
do not make any specific recommendations about normalization, but demonstrated
the SAM procedure on a single-channel Affymetrixr array and calibrated the data
using the aforementioned cube root method (page 7).
The SAM procedure requires that the data be organized in a p×n array where
p is the number of genes and n is the number of samples. The SAM procedure will
not tolerate missing values. Chu et al. (2005) recommend using a K-nearest neighbor
algorithm called KNNimpute, proposed by Troyanskaya et al. (2001), in order to
impute missing values.
The SAM procedure attempts to estimate the FDR as defined by Storey (2002)
(Chu et al., 2005). SAM does not provide any new procedure for controlling the Type I
error rate. The only difference between SAM and other procedures which reject the
11

null when the tests statistic is more extreme than a constant is the use of asymmetric
critical values (Dudoit et al., 2003).

2.2.3

Other Methods
Several approaches using linear models have been proposed to analyze mi-

croarray data (see Smyth (2004) for a nice summary). Kerr et al. (2000) propose a
general analysis of variance model for the logs of the original fluorescence measurements; however, most approaches involve a separate model for each gene. Chu et al.
(2002) propose a mixed model for single-channel experiments. Lönnstedt and Speed
(2002), Dudoit et al. (2002), and Smyth (2004) all propose models involving only a
single variance term.
Smyth (2004) proposes a technique that builds on the work of Lönnstedt and
Speed (2002). It involves hierarchical parametric models using empirical Bayes methods. The method produces moderated t-statistics in which posterior residual standard
deviations are used in place of ordinary standard deviation.
Other approaches for analyzing microarrays include discriminant methods,
such as nearest neighbor classifiers, linear discriminant analysis, and classification
trees. A thorough discussion of these methods can be found in Dudoit et al. (2000).
A statistically inferior but common method in assessing gene expression is to consider
the fold change. In this method, genes are assessed using a log2 scale. Genes with
high fold change are considered significant without regard to the within-gene variation. Therefore, a gene with high expression and high variation may be considered
significant, whereas a gene with low expression but low variation may be ignored.
12

Tanaka et al. (2000) demonstrate that selecting significant genes based solely on fold
change leads to false positives and false negatives.

2.3

Multiple Testing
The objective of most microarray experiments is to determine which genes

are differentially expressed. In a typical microarray experiment, thousands of genes
are simultaneously tested under the null hypothesis that there is no association between the expression levels and the treatments. The biological question of differential
expression can therefore be restated as a problem in multiple hypothesis testing. Microarray experiments present new challenges to the application of multiple testing
procedures because of the sheer number of tests (Dudoit et al., 2003).
Consider the problem of testing m null hypotheses where m0 are true and m1
are not. Table 2.1 summarizes the number of errors that can be committed when
testing these hypotheses. The m hypotheses are assumed to be known in advance.
The random variables W and R are observable, whereas the random variables U , V ,
T , and S, are not (Benjamini and Hochberg, 1995).

Number
Number of
not rejected
True null hypotheses
U
Non-true null hypotheses
T
W

Number
rejected
V
S
R

Table 2.1: Outcomes when testing m null hypotheses.

13

m0
m1
m

Two types of errors can be committed in a significance test. A Type I error
occurs when a gene is called significantly different when it truly is not. A Type II error
occurs when a gene is not called significantly different when it truly is. In Table 2.1
the number of Type I errors is represented by V and the number of Type II errors
is represented by T . The FWER is the probability of at least one Type I error. In
context of Table 2.1, FWER = P(V ≥ 1).
Controlling the number of errors is important when testing many hypotheses.
Researchers usually attempt to control the FWER, but there are other less standard
Type I error rates such as the Per-Comparison Error Rate and the Per-Family Error
Rate (Shaffer, 1995).
There are two levels of control of the Type I error rate. The first, strong
control, controls the Type I error rate when any subset of the null hypotheses is
true. The second, weak control, controls the Type I error rate only when all the null
hypotheses are true. In microarray settings, where it is fairly certain that some null
hypotheses are not true, it is important to have strong control (Dudoit et al., 2003).
Several approaches have been proposed to control the Type I error rate. The
most common is perhaps the Bonferroni which provides strong control of the FWER.
However, the Bonferroni approach can be too conservative in some settings. A less
conservative approach is the S̆idák procedure (S̆idák, 1967), which provides weak control of the FWER under certain circumstances. The S̆idák procedure assumes that
the p-values are independently distributed uniformly; however, microarray experiments tend to yield p-values that are dependent and have a skewed distribution. The
most conservative approach, therefore, is to use the Bonferroni method.
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Another useful technique for controlling the Type I error rate is adjusting pvalues through step up or step down procedures. These procedures consider the order
of the p-values when making adjustments. Westfall and Young (1993) show how to
calculate adjusted p-values through resampling. Dudoit et al. (2003) prefer the use
of adjusted p-values. One advantage of reporting adjusted p-values is not having
to determine the level of the test in advance. Step down procedures provide strong
control of the FWER (Westfall and Young, 1993).
Bayesian approaches to the multiple testing problem in microarray analysis
also exist. An empirical Bayes approach can be found in Efron and Tibshirani (2002).

2.3.1

The False Discovery Rate
A modern approach to the multiple testing problem is to consider the False

Discovery Rate (FDR). The FDR is the expected proportion of Type I errors among
the rejected hypotheses (Dudoit et al., 2003). Controlling the FDR is of practical
utility when the desire is to produce a large list of significant genes that contain a
relatively small number of false positives. In other words, considering the FDR can
help researchers identify a large group of significant genes while still providing some
control over error rates.
Benjamini and Hochberg (1995) pioneered the work on the False Discovery
Rate. Their methodology provides weak control of the Type I error rate. Storey
and Tibshirani (2001) later proposed the Positive False Discovery Rate (pFDR). The
pFDR provides strong control of the Type I error rate. The difference between the
FDR and the pFDR is subtle. The FDR proposed by Benjamini and Hochberg (1995)
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is calculated based on the probability that there is at least one significant gene. The
pFDR proposed by Storey (2002) assumes that this probability is essentially equal to
one. Specifically, the FDR and pFDR are defined as
Ã ¯
!
V ¯¯
FDR = E
¯R > 0 P(R > 0)
R¯
!
Ã ¯
V ¯¯
pFDR = E
¯R > 0 .
R¯

(2.1)
(2.2)

The FDR and the pFDR are asymptotically equivalent for a fixed rejection
region, so for large m the two estimates are basically equivalent. This is due to the
fact that for large m P(R > 0) ≈ 1 (Storey, 2002). The pFDR is preferred because
it has greater power, becomes better as the number of tests increase, provides better
estimates for small rejection regions, and provides strong control of the Type I error
rate. In this document the term FDR will refer to the pFDR defined by Storey and
Tibshirani (2001).
One advantage of the FDR is that it is valid when there are dependencies
between p-values (Benjamini and Yekutieli, 2001). The p-values in microarray experiments tend to be dependent due to genetic pathways that interact in order to produce
some overall process (Storey and Tibshirani, 2001). The FDR can be estimated by
using resampling techniques (Good, 2001) that take these dependencies into account.
Efron (2004) has modified the FDR by using empirical Bayes methods to
estimate it in an infinitesimal interval. His method calculates what he calls the local
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FDR. The local FDR is closely related to the FDR developed by Benjamini and
Hochberg (1995).

2.3.2

The Miss Rate
The Miss Rate (MR) complements the FDR. Whereas the FDR measures the

proportion of false positives, the MR measures the proportion of false negatives in
an interval near the rejection region. In other words, the MR is the proportion of
genes that are truly differentially expressed among those declared non-significant for
a specified interval (Taylor et al., 2005).
The quantity E(T /W ) is what Genovese and Wasserman (2003) call the False
Non-Discovery Rate or what Tibshirani (2005) calls the False Negative Rate (FNR).
This quantity is typically not of practical importance since most of the expression
values in T will tend toward zero. A more useful quantity is the proportion of false
negatives in an interval, (c0 , c), near the rejection region.

Null true
Alternative true

|Ti | in (c0 , c) |Ti | > c(Reject)
U0
V
T0
S
W0
R

Table 2.2: Outcomes when testing hypotheses in the interval (c0 , c).

Table 2.2 displays various outcomes for testing m genes the interval (c0 , c).
The MR is defined as

µ
MR(c0 , c) = E
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T0
W0

¶
.

(2.3)

The MR is a cautionary statistic that is to be used when evaluating the False Discovery
Rate. It has been shown that when the FDR is very low, the MR can be quite high
(Taylor et al., 2005). Therefore, it is advisable that the MR be routinely reported
along with the FDR.

2.3.3

Tail Strength
Taylor and Tibshirani (2006) propose an overall measure of significance for a

set of hypothesis tests. Their method compares the distribution of p-values to the
uniform distribution and calculates a measure called the Tail Strength.
The TS can be thought of as roughly the percentage of significant test statistics
due to chance. For example, if T S = 0.655, then there are 65.5% more significant
test statistics on average than would be expected by chance alone. A uniformly
distributed set of p-values would have a TS value close to 0. On the other hand, as
p-values bunch up near 0, the TS approaches 1.
In the SAM procedure, the null distribution is simulated through random
permutation of the data. Thus, the ordered test statistics can easily be converted to
p-values by taking advantage of the simulated null distribution. Taylor and Tibshirani
(2006) suggest calculating p-values as the proportion of test statistics in the null
distribution that exceed the observed test statistic. Once the test statistics have been
converted to p-values the TS can be calculated.
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Chapter 3
Materials and Methods
This project compares two popular methods for analyzing genomic data. The
first method is a mixed models approach, and the second is the Significance Analysis
of Microarrays. These analyses are compared using microarray data from a mouse
pregnancy study.

3.1

Mixed Models Approach
The mixed models approach uses mixed models to both normalize and analyze

microarray data. A mixed model is a linear model that includes both fixed and
random effects. Fixed effects are assumed to be constant. Random effects are assumed
to be randomly selected from an infinite population. In their normalization and gene
models, Wolfinger et al. (2001) specified fixed treatment effects and random array
effects. The treatment effects were assumed to be constant while the array effects
were assumed to be randomly selected from all possible array effects.
The mixed models approach is carried out using SAS Proc Mixedr (Littell
et al., 2006). The random effects, including the error term, are assumed to come
from a normal distribution. The Mixed Procedure estimates the covariance structure
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using a restricted maximum likelihood (REML) method. One advantage of the REML
method is that it accommodates missing data.
The mixed models approach requires two separate model specifications, one for
the normalization model and another for the gene model. The normalization model is
applied to the entire data set. It includes effects due to the experimental conditions,
not effects due to the actual genes themselves. Because the normalization model is
applied to the entire data set, it is computationally advantageous to specify a fairly
simple model. Models that include many terms or complex variance structures can
take days to run.
The residuals from the normalization model are passed to the gene models,
and a separate gene model is run for each gene. The gene model includes effects
that are due to the actual genes themselves. The gene models are computationally
intensive, because a separate REML optimization problem is solved for each gene.
Furthermore, the number of genes that can be analyzed sequentially depends on the
amount of available memory. Again, specifying fairly simple models is computationally advantageous.
The mixed models approach identifies significant genes by testing the pairwise
treatment comparisons in the gene model. Due to a large number of genes in any
given microarray experiment, the number of pairwise comparisons can number in
the tens of thousands. Therefore, Wolfinger et al. (2001) suggest using a Bonferroni
correction to control the FWER.
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3.2

Significance Analysis of Microarrays
The Significance Analysis of Microarrays compares ordered test statistics to

their expected values. The expected order statistics are estimated using resampling.
The calculations for the SAM procedure are carried out in the R environment using the
samr package. If desired, the SAM procedure can be manipulated using a Microsoft
Excelr interface. Details for the R package and the Excelr interface can be found at
www-stat.stanford.edu/∼tibs/SAM.
The SAM procedure requires the data to be in a p × n array where p is the
number of genes and n is the number of samples. Thus, there is one measurement
per gene per sample. Furthermore, there can be no missing data. Missing data can
be imputed using the impute package for the R environment.
The SAM procedure itself does not do any normalization. A common normalization procedure is the print-tip lowess normalization proposed by Yang et al.
(2002). This procedure is part of the sma package for the R environment. It has five
steps: (1) subtract out the background, (2) calculate the M -values and the A-values,
(3) apply lowess curves to the M A-plot for each print-tip, and (4) use the residuals as
normalized values. After normalizing each array, the expression values for all arrays
should be examined. If there are substantial scaled differences between arrays, then
a scale normalization can be considered.
Once the data has been normalized and fit into a p × n array with no missing
values, it can be passed through the SAM procedure. There are seven basics steps
in the SAM procedure: (1) compute the observed order statistics for all genes, (2)
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estimate the expected order statistics, (3) plot the observed order statistics versus the
expected order statistics, (4) choose an arbitrary cutoff (∆), (5) find the significant
genes above and below ∆, (6) estimate the FDR, and (7) calculate the MR.

3.2.1

Compute the observed order statistics for all genes.
In the SAM procedure, effect differences are estimated with a statistic called

the relative difference. It has the following form:

di =

ri
,
si + s0

(3.1)

where ri represents the score, or unstandardized change in gene expression, si represents the gene specific scatter, or the standard deviation of repeated gene expression,
and i is a gene index. The quantity s0 is the fudge factor or exchangeability factor and
is used in an attempt to make ri and si independent, particularly at low expression
levels.
The form of di depends on the type of data. For a two-class unpaired experiment the relative difference is basically a two sample t-test statistic. For a multi-class
experiment, the relative difference is defined in terms of Fisher’s linear discriminant.
Fisher’s linear discriminant is the linear combination that maximizes the betweenclass variance with respect to the within-class variance (Hastie et al., 2001). In the
SAM procedure the between-class variance (ri ) and the within-class variance (si ) are
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defined as

ri

v
u
K
u X
Y
X
t
=
{
nk /
nk }
nk (x̄ik − x̄i )2 ,

(3.2)

k=1

si

v
u P
K
u
1/nk X X
t
P
=
(xij − x̄ik )2 .
(nk − 1) k=1

(3.3)

It is important to note that ri and si for the multiclass design are positive, and
therefore di can only be positive. This is somewhat unique in that the other functions
utilized by SAM can take on both positive and negative values.
The variance of di tends to be high for low expression values. The fudge factor
s0 is estimated in order to keep ri independent of si (Tusher et al., 2001). The value
s0 is calculated as the αth percentile of si that minimizes the coefficient of variation
for the median absolute deviations of di . The technique for adding a fudge factor
to the denominator is outlined in Storey (2002). Calculation details can be found in
Appendix A.2.
It is important to note that (1) there are other ways to make the distribution
of di independent of the levels of si , (2) the SAM software does not warn the user
when s0 has reached the upper bound, and (3) the SAM software does allow the
user to override the calculation of s0 . For example, the user can set s0 to zero if no
adjustment to the denominator is desired. Finally, the relative differences, di , are
ordered to create the observed order statistics d(i) .
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3.2.2

Estimate the expected order statistics.
Data for a typical SAM experiment can be thought of as a p × n array where

p is the number of genes and n is the number of samples. Note here that typically
there are several thousand genes (p), whereas there are typically only a handful of
samples (n).
The expected ordered statistics are estimated from random permutations of
the columns in the p × n array. There are five steps in creating the expected order
statistics: (1) randomly permute the samples (or columns), (2) calculate the test
statistic d∗i for each gene, (3) order the test statistics statistics d∗(i) , (4) repeat B
P
times, and (5) estimate the expected order statistics with d¯(i) = (1/B) b d∗b
(i) .
In the SAM procedure the samples (or columns) of the data are randomly
permuted and the order statistics are recalculated. This process is repeated a sufficient
number of times in order to estimate the distribution of the expected value of the
order statistics. The random permutations preserve the correlation structure between
rows.

3.2.3

Plot observed against expected order statistics.
The observed order statistics (d(i) ) are plotted against the expected order

statistics (d∗(i) ). If there is no treatment effect, then the plot will fall roughly on a
diagonal line. If there is a treatment effect the plot will deviate from the expected
line. The genes that fall furthest from the diagonal line indicate significance.
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3.2.4

Choose an arbitrary cutoff ∆
Let ∆ be the maximum allowable absolute difference between an observed

statistic and its expected statistic. For any gene i where |d(i) − d¯(i) | > ∆, gene i is
called significant. The user chooses the cutoff with respect to an acceptable FDR.
The SAM procedure produces a table showing the relationship between ∆, the FDR,
and the number of genes called significant.

3.2.5

Find the significant genes above and below ∆
The genes above and below ∆ are declared significant. In the multiclass

method all values d(i) are positive, and there is only one cutoff. All values above
the cutoff in the multiclass method are declared significant.

3.2.6

Estimate the FDR
The FDR is an estimate of the percentage of false positives. It is calculated

by dividing the number of false positives by the number of genes called significant.
In other words, SAM estimates the FDR in the following way:

[ = Number of false positives .
FDR
Number of significant genes

(3.4)

The number of significant genes is based on the user’s choice of ∆. The number
of false positives, however, has to be estimated. It is calculated by determining the
number of genes in each of the B random permutations with values exceeding ∆
(there will be B values). The estimated number of false positives is the median value
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from the B permutations. Alternatively, the 90th percentile of the B permutations
can be used.
The number of false positives tends to be biased upwards (Storey and Tibshirani, 2001). This is due to the fact that the method used to calculate the number of
false positives assumes that there is no treatment effect and no truly significant genes.
Typically, however, there is a treatment effect and significant genes are expected to
be encountered. Therefore, the number of genes expected to be called significant not
only includes the number of false positives but the number of genes that truly are
significant.
In order to correct for the upward bias, the proportion of truly null genes
(i.e., unaffected genes), π0 , is estimated. If (q25 , q75 ) represent the range of values
determined by the first and third quartiles of the expected order statistics, then the
number of observed order statistics expected to be found in this interval is one half
the total number of genes. The proportion of true null genes, π0 , is estimated as the
number of observed order statistics in the (q25 , q75 ) interval divided by half the total
number of genes. In mathematical notation, π̂0 = #{di ∈ (q25, q75)}/(p/2). The
SAM procedure does not allow for alternative quantiles to be used. If π̂0 exceeds
one, then π̂0 is set to one (Chu et al., 2005). The number of false positives is then
multiplied by the estimated proportion of true null genes π̂0 .
Storey and Tibshirani (2003) propose an alternative method for calculating
π̂0 based on p-values alone. The approach assumes that the distribution of p-values
under the null hypothesis is uniform. The proportion of null p-values then is estimated
from the level or flat part of the distribution of actual p-values. Specifically, if the
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tuning parameter λ is the value where the distribution of p-values levels off, then
π̂0 (λ) =

#{pi >λ;i=1,...,m}
.
m(1−λ)

The FDR estimated by the SAM procedure is equivalent to

setting λ = 0.5 (Storey and Tibshirani, 2001).
As an example calculation of the FDR, consider the unpaired two-class randomly generated data set in which there are 20 samples of 1000 genes that are permuted 100 times. Suppose the middle half of the permuted order statistics d∗b
(i) fall
between the range of values (−0.27, 0.27). However, only 472 genes with observed
order statistics d(i) fall in that same range. Therefore the estimated proportion of
true null genes is π̂0 = 472/500 = 94%. In other words, about 94% of the genes are
not significant. Furthermore, suppose that when ∆ = 0.2 the number of significant
genes is 66, and the median number of false positives from the 100 permutations is
\
15. The False Discovery Rate then is estimated as F
DR = 95% × 15/66 = 21%. In
other words, 21% of the genes found at ∆ = 0.2 are estimated to be false positives.

3.2.7

Calculate the Miss Rate
The Miss Rate (MR) is the proportion of genes that are truly differentially ex-

pressed among those declared non-significant in an interval near the cutoff determined
by ∆. The SAM procedure estimates the MR by the following:
b
d 0 , c) = 1 − π̂0 U0 ,
MR(c
W0

(3.5)

where π̂0 is the estimated proportion of true null genes, W0 is the total number of
b0 is the estimated number of false negatives.
genes declared non-significant, and U
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The interval (c0 , c) defines an interval near the cutoff. The quantity W0 is observed,
b0 is estimated from the random permutations used in the SAM
whereas the quantity U
procedure (Taylor et al., 2005).
It should be noted that the Miss Rate (along with the FDR and local FDR)
are unidentifiable unless π0 is known. This is the reason for finding conservative
estimates of π0 which will in turn lead to conservative estimates of the MR as well
as the FDR. The method used in SAM provides conservative estimates of π0 (Storey
and Tibshirani, 2001).
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Chapter 4
Mouse Pregnancy Data
Microarray experiments are conducted to identify differential gene expression.
Researchers wish to know which genes are involved with which treatments. For example, a gene that is significantly expressed when exposed to one treatment and not
to another indicates that the significant gene and treatment combination is involved
in some underlying biological pathway. The mouse pregnancy data was designed to
find which genes and treatments influence pregnancy.

4.1

Treatments
The mouse pregnancy data came from an experiment performed in 2003 at the

University of Utah. There were two types of mice. The wild type mice were genetically
unaltered and served as the control. The knock-out mice were missing a pregnancyrelated gene that had been genetically removed. The mice were then exposed to either
a treatment or a placebo. The treatment was lipopolysaccharide (LPS), a molecule
that induces labor. The placebo was a saline solution (SAL). The reference type mice
were exposed to neither the treatment nor the placebo. Ribonucleic Acid (RNA) was
then sampled from each mouse and applied to a microarray containing known genes.
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The RNA combined to the genes on the microarray and the expression value for each
gene was recorded.
Five types of mice were used in the experiment, one for each treatment combination. The treatment combinations were: wild type mice receiving lipopolysaccharide (LPS:B6), knock-out mice receiving lipopolysaccharide (LPS:KO), wild type
mice receiving saline (SAL:B6), knock-out mice receiving saline (SAL:KO), and reference mice (REF). Messenger RNA (mRNA) was harvested from each type of mouse
and reverse transcribed to form cDNA. The cDNA was then tagged using a fluorescent dye. The cDNA from each treatment was tagged with a green dye (Cy3) and
hybridized to one of the arrays. The mRNA from separate reference mice was also
harvested and reverse transcribed to form cDNA. The cDNA from the reference was
tagged with a red dye (Cy5) and applied to all the arrays.

4.2

Microarrays
The mouse pregnancy data tested 21,529 unique genes. The entire complement

of genes did not fit onto one array, so three slides (A, B, and C) were used instead of
one. The genes were spotted onto the microarrays using a print-tip that can lay down
several gene spots at once. Slides A and B were spotted using a 20 × 20 print-tip.
In other words, 400 probes were spotted each time the print-tip touched the array.
Slide C was spotted using a 16 × 21 print-tip. All three slides were printed in a 12 × 4
array. In other words, the print-tip groups were printed in 12 rows and 4 columns.
In general, a gene was tested on a single slide. However, a significant number
of genes were tested on multiple slides. Figure 4.1 shows the gene pattern for slides
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Figure 4.1: Gene pattern for one group of three slides. The gene spots were laid out
in two side-by-side blocks, creating at least two replicates of each gene spot. Some gene
spots were replicated four times, twice on one array and twice on another. Reference
spots (white) also appear on each of the slides.

A, B, and C. The gene pattern on the left half of each slide was duplicated on the
right half, forming two blocks on each slide.
Table 4.1 shows the number of genes replicated on each slide. Most gene spots
(18,618) were replicated twice on each slide, appearing once in each block. Some
spots (2,910) were replicated four times, appearing twice on one slide and twice on
another. One spot was replicated 10 times.
Each slide was printed with a significant number of reference spots as well as
known genes. These reference spots can be used during the normalization step of
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Reps A Genes B Genes C Genes AB Genes BC Genes
2
9,214
5,751
3,653
.
.
4
1
1
.
44
2,864
10
.
1
.
.
.
Total
9,215
5,753
3,653
44
2,864

Total Genes
18,618
2,910
1
21,529

Table 4.1: Gene replication. Most genes were replicated twice (once on each block).
Some genes were replicated four times, and one gene was replicated 10 times. Slide A
contained far more genes than slides B and C.

analysis, but do not correspond to genes of interest. Table 4.2 shows the number of
reference spots in each slide. Roughly 10% of the overall spots were reference spots.

Slide
A
B
C
Total

Gene Spots Reference Spots Total Spots
18,520
680
19,200
17,332
1,868
19,200
13,034
3,094
16,128
48,886
5,642
54,528

Table 4.2: Reference spots. Each slide contained reference spots that were not associated with genes of interest. The reference spots aid in the normalization process.

4.3

Measurements
Each group of three slides was replicated 16 times, making 48 arrays in all.

The arrays were organized into five groups, one group for each treatment. Each
treatment (cDNA tagged with green dye) was then hybridized to one group of arrays.
The (LPS:B6) treatment was hybridized to arrays 1 − 12, the (LPS:KO) treatment
was hybridized to arrays 13 − 24, the (SAL:B6) treatment was hybridized to arrays
25 − 36, the (SAL:KO) treatment was hybridized to arrays 37 − 45, and the reference
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treatment was hybridized to arrays 46 − 48. The reference treatment tagged with red
dye was hybridized to all the groups (arrays 1 − 48). Thus, each array received one
of five treatments (green dye) and the reference treatment (red dye).
The mouse pregnancy data consisted of genes g (g = 1, . . . , 21529), dyes d
(d = 1, 2), treatments t (t = 1, . . . , 5), arrays a (a = 1, . . . , 48), and gene spots s(a).
After the cDNA hybridized with the genes spotted on the microarrays, a foreground
and background image was measured for each dye color. The process resulted in
four measurements per gene: red foreground (Rfgtas ), red background (Rbgtas ), green
foreground (Gfgtas ), and green background (Gbgtas ). The background corrected log2
intensities (ygdtas ), the log ratios (Mgtas ), and the log averages (Agtas ) were defined
as,

yg1tas = log2 (Gfgtas − Gbgtas ),

(4.1)

yg2tas = log2 (Rfgtas − Rbgtas ),

(4.2)

Rfgtas − Rbgtas
= yg1tas − yg2tas ,
Ggtas − Gbgtas
yg1tas + yg2tas
=
.
2

Mgtas = log2

(4.3)

Agtas

(4.4)

Notice the background corrected log2 intensities require an extra subscript, d, for
dye. This subscript is use to identify the measurement on arrays 45 − 48 which were
exposed to the reference treatment in both the red and green dyes. Also notice that
the red dye (d = 2) will always be associated with the reference treatment (i = 5).
The expression values in the mouse pregnancy data were measured using a
laser scanner and imaging software. The software measured the quality of each spot
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and flagged those spots that did not conform to predefined tolerances. Reasons for
flagging low quality spots include background contamination, signal contamination,
and shape irregularity. Flags were widespread in the data. Approximately 82% of
the genes had at least one flag for one of the expression values. Approximately 2% of
the genes had flags for all expression values.
Examining arrays for spatial effects can be very important in a microarray
analysis. The mouse pregnancy data showed severe distortions in the background
images. Figure 4.2 shows the log ratios for the background measurements only, i.e.
log2 (Rbgtas /Gbgtas ). There was a bubble-shaped distortion that appeared on all of
the B slides. The A slides showed a few smear marks, and the C slides showed a few
large spots.
Figure 4.3 shows the Mgtas values for the experiment. Most arrays were predominantly green, which indicates that the treatment was expressed more strongly
than the reference. There was large variability between arrays.

34

Figure 4.2: Background log ratios. The images show a bubble that runs through the
B slides and other distortions in the A and C slides.
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Figure 4.3: Log ratios. Most arrays appear predominantly green, meaning the treatment is expressed more strongly than the reference.
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Chapter 5
Mixed Models Analysis
There were four basic steps in the mixed models analysis: (1) organize the
data, (2) normalize the data, (3) run the gene models, and (4) identify significant
genes. An investigation of treatment effects was also included as part of the mixed
models analysis.

5.1

Organize the data
The background corrected log2 intensities were used in the mixed models anal-

ysis. Intensities with negative or zero expression (i.e. the background image was larger
than or equal to the foreground image) were not used in the analysis, and flagged
data were removed, as suggested by Wolfinger et al. (2001).
The mixed models approach requires the data to be in a tall format (i.e. one
measurement per record) as opposed to an array format (i.e. multiple measurements
per record). Therefore, each gene spot is associated with two records, one for the
treatment (green dye) and one for the reference (red dye).

5.2

Normalize the Data
The purpose of the normalization model is to remove experimental effects

that are common across all genes. In other words, normalization attempts to remove
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main and interaction effects not associated with individual genes. The mixed model
procedure uses one normalization model for the entire set of data. Let ygdtas be the
background corrected log2 intensity for gene g, dye d, treatment t, array a, and spot
s. The normalization model was:

ygdtas = µ + Tt + Aa + (T A)ta + ²gdtas ,

(5.1)

where µ represents an overall mean value, T is the treatment effect, A is the array
effect, and T A is the interaction effect of arrays and treatments. The treatment effect
T is a fixed effect. The other effects A, T A, and ² are random effects which are
distributed normally with mean 0 and variances σA2 , σT2 A , and σ²2 respectively. The
fixed effect T and the random effects A and T A were all highly significant. The
normalized values are the residuals from this model, rgdtas = ygdtas − ŷta .
Figure 5.1 shows the normalized intensities by array. Ideally, all the box plots
would show similar variances and distributions. However, the reference intensities
tend to have a larger interquartile range. The distributions also tend to be negatively
skewed.

5.3

Run the Gene Models
After the expression values were normalized, the effects due to each gene were

assessed. A separate model was fit to the data associated with each unique gene.
Each model had the same form. Let rgdtas be the normalized, background corrected
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Figure 5.1: Normalized gene intensities by array for the mixed models analysis. The
distributions tend to be negatively skewed. The reference distributions tend to have
larger interquartile ranges.

log2 intensities from Model 5.1. The gene model was:

rgdtas = Gg + (GT )gt + (GA)ga + (GS)gs(a) + γgdtas ,

(5.2)

where G represents the overall mean value for gene g, GT is the fixed effect for
treatment t, GA is the random effect for array a, and GS is the random effect for
spot. Including G before the effects indicates that all these effects are with respect
to gene g. The random effects GA, GS, and γ are distributed normally with mean 0

39

2
2
and variances σGA
, σGS
, and σγ2g respectively. The mixed models approach assumes
g
g

heterogeneous variances among genes.
There were 21,529 unique genes in the mouse pregnancy data. There were 480
genes removed due to negative expression and/or poor spot quality. An additional
338 genes were removed due to insufficient data (i.e. observations with so many
negative values and flags that the the parameters could not be estimated). Finally,
908 genes produced F -statistics for the treatment effect that were equal to zero. These
genes had zero degrees of freedom for estimating the error. In all, the mixed models
approach successfully analyzed 19,803 genes.
Table 5.1 shows the degrees of freedom for a typical gene model. The degrees
of freedom for each gene model varied depending on the gene. and some genes were
replicated twice as often as other genes. Also, some genes were missing observations
due to poor quality or negative expression.

Source
DF
Intercept
1
Treatment
4
Array
15
Spot(Array) 15
Error
29
Total
64
Table 5.1: Degrees of freedom for a typical gene model. Some genes have more degrees
of freedom due to extra replication, while others have fewer degrees of freedom due to
missing values.

40

5.4

Identify Significant Genes

All pairwise comparisons for the five treatments were computed on the reµ ¶
5
sulting 19,803 genes. There were
= 10 comparisons for genes with all five
2
treatments.

There were fewer comparisons for genes with missing observations.

In all, there were 194,462 pairwise comparisons. A t-test was performed on each
comparison. A Bonferroni adjustment was used to calculate the corrected alpha as
αc = 0.05/194,462 = 2.57 × 10−7 . The cutoff resulted in 9,238 significant pairwise
comparisons from 3,542 unique genes. Table 5.2 shows sample output for the mixed
analysis. Only the 20 most significant pairwise comparisons are included.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Gene
BG076245
BG076245
BG076245
BG076245
BG076245
BQ550593
BG076245
BQ550593
BQ554441
BQ550593
BQ552581
BQ550593
BQ552581
BQ553339
BQ554441
BQ550593
BQ553335
BQ552581
BQ554441
BQ554441

Strain1
B6:Sal
B6:Sal
B6:LPS
KO:Sal
KO:LPS
B6:Sal
B6:LPS
B6:Sal
B6:Sal
KO:Sal
B6:Sal
B6:LPS
B6:Sal
B6:Sal
B6:Sal
KO:LPS
B6:Sal
B6:LPS
KO:Sal
KO:LPS

Strain2
Ref
KO:LPS
B6:Sal
Ref
KO:Sal
Ref
KO:Sal
KO:LPS
Ref
Ref
KO:LPS
B6:Sal
Ref
Ref
KO:LPS
KO:Sal
Ref
B6:Sal
Ref
KO:Sal

Estimate
−3.55
−4.22
4.11
−3.11
3.79
−3.31
3.67
−4.03
−1.85
−3.18
−3.52
3.79
−2.40
−3.23
−2.35
3.90
−2.14
3.18
−1.83
2.33

StdErr
0.05
0.07
0.07
0.06
0.07
0.08
0.08
0.11
0.04
0.09
0.09
0.11
0.06
0.07
0.06
0.11
0.06
0.09
0.05
0.07

DF
55.00
55.00
55.00
55.00
55.00
60.00
55.00
60.00
56.00
60.00
55.00
60.00
55.00
50.00
56.00
60.00
57.00
55.00
56.00
56.00

Tval
−72.96
−61.60
58.93
−54.84
50.81
−43.95
48.57
−38.27
−41.24
−36.70
−40.08
36.00
−39.76
−43.92
−37.75
34.30
−36.28
37.44
−36.38
35.12

−Log10p
55.70
51.71
50.66
48.97
47.18
46.62
46.13
43.13
42.87
42.08
41.67
41.60
41.48
40.88
40.79
40.40
40.35
40.09
39.93
39.11

Table 5.2: Output for the top 20 significant genes in the mixed analysis.
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5.5

Investigate Treatment Effects
Table 5.3 shows the number of significant pairwise comparisons for each of the

10 treatment combinations. The highest number of significant differences occurred
between the four treatments and the reference. A large number of significant comparisons occurred when comparing mice exposed to LPS versus saline. However, very
few significant comparisons occurred when comparing wild type mice to knock-out
mice.

B6:SAL
KO:LPS
KO:SAL
Ref
Total

B6:LPS B6:SAL
668
.
17
1,023
640
26
945
1,696
2,270
2,745

KO:LPS KO:SAL
.
.
.
.
843
.
1,650
1,730
2,493
1,730

Table 5.3: Significant pairwise comparisons.
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Total
668
1,040
1,509
6,021
9,238

Chapter 6
SAM Analysis
There were five basic steps in the SAM analysis: (1) organize the data, (2)
Normalize the data, (3) aggregate, reduce, and impute the data, (4) run the SAM
analysis, and (5) identify significant genes. An investigation of treatment effects was
also included as part of the SAM analysis.

6.1

Organize the Data
The background corrected log2 ratios (i.e. M -values) were used in the SAM

analysis. Log averages (i.e. A-values) were also used to normalize the data. Gene
intensities with negative or zero expression (i.e. the background image was larger than
or equal to the foreground image) were not used in the analysis (Smyth and Speed,
2003). Data flagged for poor quality were also left out of the analysis (Wolfinger
et al., 2001).

6.2

Normalize the Data
The spots on the mouse pregnancy microarrays were printed in 48 print-tip

groups. The data were normalized using print-tip lowess normalization. The A-values
were compared to the M -values by print-tip group. Independent lowess curves were
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Figure 6.1: Non-normalized print-tip M -plot (Left) and normalized print-tip M plot (Right) for the first three arrays. The non-normalized plot shows patterns in the
expression values for every four print-tip groups. The normalized plot shows expression
values that look similar across print-tip groups and between slides.

fit for each print tip group and the residuals were then calculated. The residuals
constitute normalized expression values.
Figure 6.1 (Left) shows the non-normalized M -values for the 48 print-tip
groups in the first three arrays (i.e. slides A,B, and C in the first sample). There
appears to be a pattern in every four print-tip groups, especially for slides A and
C. This is probably due to the fact that the microarrays were printed 4 groups wide
by 12 groups high. The normalized M -values for the 48 print-tips can be seen in
Figure 6.1 (Right). The expression values now appear to be independent of print-tip
group. Furthermore, the expression values look similar between slides.
The non-normalized M -values and A-values for all 16 replications can be seen
in Figure 6.2 (Left). Notice the strong relationship between the A-values and the
M -values. Ideally, the expression difference would be independent of the expression
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Figure 6.2: Non-normalized (Left) and normalized (Right) MA-plots for all 16 replications. The non-normalized plot shows that small M -values appear to be highly correlated with small A values. The normalized plot shows that the M -values and A-values
appear to be much less dependent.

average. However, Figure 6.2 (Left) indicates that M -values tend to be small when
the A-values are small. The normalized M -values and A-values can be seen in Figure 6.2 (Right). A slight dependency remains between the log averages and the log
ratios. In general, however, the M -values and A-values appear to be less dependent
than in Figure 6.2 (Left).
Print-tip normalization is technically a within-array normalization technique.
However, it is often sufficient for between-array normalization as well. Figure 6.3 (Left)
shows the normalized M -values for all slides. The M -values for each slide center
around zero. However, the M -values tend to have different inter-quartile ranges between arrays but not between slides. Each print-tip group for each array in each slide
was normalized independently. The pattern between arrays, therefore, suggests that
there is an array effect but not a slide effect.
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Figure 6.3: Normalized M -plot (Left) and normalized between-array M -plot (Right).
The normalized M plot shows large variation between arrays. The normalized betweenarray plot shows the arrays after the arrays have been scaled to have equal median
absolute deviations.

The M -values can be normalized between arrays; however, it has been argued
that normalizing between arrays can create more noise than it resolves (Smyth and
Speed, 2003), but when there are substantial differences between samples, the samples
can be scaled so that they all have the same median absolute deviation. The mouse
pregnancy data are very noisy and show slide to slide variability in expression values;
therefore, the data were scale normalized to correct for between-array variability. The
final normalized M -values can be seen in Figure 6.3 (Right).

6.3

Aggregate, Reduce and Impute the Data
The SAM procedure requires data be in the form of a p × n matrix where

p is the number of genes and n is the number of samples. This structure requires
that replicated genes within samples be aggregated into one expression value per

46

sample. The SAM procedure will not tolerate any missing values; therefore, missing
values must be eliminated or imputed. In the SAM analysis 4,179 out of 21,529 genes
were thrown out due to a combination of negative gene expression, poor quality, and
imputation rules.
The mouse pregnancy data consisted of 16 samples (i.e. 16 replications). Approximately 86% of the genes were replicated twice, while all but one of the other
14% were replicated four times. In order to fit the mouse pregnancy data into a p × n
matrix, it was decided that the replicates would be averaged within each sample,
creating one expression value per gene per sample.
The SAM procedure requires that each sample be replicated at least twice. In
the mouse pregnancy data, there were four samples for the LPS:B6, LPS:KO, and
SAL:B6 treatment groups; there were three samples for the SAL:KO treatment group;
and there was one sample for the REF treatment group. The REF treatment group
could not be used in the SAM analysis because it was not replicated.
The SAM procedure will not tolerate any missing values in the p × n data
matrix. It is necessary to either throw out genes with any missing observations, or
impute values for the missing observations. Missing values occurred in the mouse
pregnancy data for two reasons: first, they occurred when either the red or green
scan had a background value larger than its foreground value; second, they occurred
when intensities were flagged for poor spot quality.
After accounting for flags and background correction, 20% of all observations
were missing with 40% of the genes having at least one missing value. It was decided
that any gene without at least one observation in each of the four treatment groups
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would be discarded from the SAM analysis. This rule eliminated 20% of the total
genes.
After eliminating genes without at least one gene intensity per treatment
group, 5.6% of the gene intensities were still missing values. A K-nearest neighbor algorithm called KNNimpute proposed by Troyanskaya et al. (2001) was used to
impute the remaining missing values. For each gene with missing values the KNNimpute algorithm finds K-similar genes that do not have those same missing values. By
default, similarity is defined as Euclidean distance, and K is set to 10. Weights based
on the similarity are then calculated for the K-similar genes. A weighted average
of the K-similar genes is then used to impute the missing values. The algorithm is
robust, with a maximum of 10% decrease in accuracy with 20% of the data missing
(Troyanskaya et al., 2001).

6.4

Run the SAM Analysis
The Significance Analysis of Microarrays (SAM) was performed after the

mouse pregnancy data had been normalized, aggregated into a p × n array, and
imputed for missing values. The SAM analysis utilized the multiclass method to
account for differences in the following four treatments: (1) LPS:B6, (2) LPS:KO,
(3) SAL:B6, and (4) SAL:KO. The multiclass method uses Fisher’s linear discriminant to essentially compute an F statistic for each gene.
The SAM procedure was used to calculate the expected order statistics. The
default, B = 100 permutations, was used to estimate the null distribution. The
exchangeability factor, s0 , was estimated at 0.171, and the percent of null genes, π0 ,
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Figure 6.4: SAM plot. The observed order statistics are plotted against the estimated
expected order statistics. The dotted line shows ∆ = 0.55. Significant genes are those
with statistics above the dotted line.

was estimated at 54.8%. Figure 6.4 shows the observed verses the expected statistics.
Note that the test statistics are greater than zero due to the multiclass method.
The Tail Strength (TS) for this SAM analysis was 0.56 with a 90% confidence
interval of (0.26, 0.87). As the confidence interval suggests, the mouse pregnancy data
are extremely noisy.

6.5

Identify Significant Genes
The FDR was calculated for various cutoffs. Table 6.1 shows when ∆ = 0.0

that any gene with a relative difference greater than 0.0194 is significant. There were
17,348 such genes. The estimated number of false positives was 9,510. The median
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method for estimating the FDR was used. In other words, the estimated number of
false positives was the median value of the estimated false positives for each of the B
permutations. The FDR for ∆ = 0 was 9,510/17,348 = 54.82%.

1
2
3
4
5
6
7
8
9
10

delta
0.0000
0.0500
0.1000
0.1500
0.2000
0.2500
0.3000
0.4000
0.5000
0.6000

# med false pos
9510
6770
2821
999
351
121
48
8
2
1

# called
17348
14745
10179
6992
4863
3451
2623
1673
1153
817

median FDR
0.5482
0.4592
0.2772
0.1429
0.0721
0.0350
0.0183
0.0049
0.0014
0.0007

cuthi
0.0194
0.2037
0.3439
0.4555
0.5550
0.6468
0.7279
0.8758
1.0136
1.1466

Table 6.1: False Discovery Rates for various cutoffs.

For the SAM analysis, an FDR of 5% was considered satisfactory, so ∆ was
set to 0.22. The 4,152 genes with test statistics greater than the cutoff (0.595) were
considered significant. An FDR of 5% would suggest that 208 out of the 4,152 genes
were false positives.
The Miss Rate (MR) estimates the percentage of false negatives near the cutoff. That is, the MR estimates the percentage of genes that are significant, but not
declared significant for a given interval. The table of MR percentages is in Table 6.2.
The cutoff boundary for the SAM analysis was 0.595. For the genes nearest this
boundary, 79.57% are false negatives. The high percentage is due in part to a low
choice of FDR. As the FDR increases, the percentage of false positives increases and
the percentage of false negatives decreases.
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1
2
3
4
5

Cutpoints
0.438 → 0.464
0.464 → 0.493
0.493 → 0.524
0.524 → 0.558
0.558 → 0.595

Miss Rate(%)
58.01
62.05
68.48
74.42
79.57

Table 6.2: Miss Rates for the the multiclass SAM analysis.

Table 6.3 shows sample output for the SAM analysis. Only the 20 most significant genes are included.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Row
13270
12465
17079
14971
12722
8199
15236
17248
10492
9578
3624
13603
6043
5443
13454
5703
4254
17069
15908
9792

Gene ID
BQ552581
BQ550593
BQ562802
BQ557066
BQ551218
BG076245
BQ557743
C79033
BG084405
BG080268
BG067921
BQ553339
BG072303
BG071178
BQ553020
BG071644
BG069214
BQ562771
BQ559603
BG081062

Rel Diff
5.11
5.03
4.98
4.92
4.82
4.81
4.79
4.49
4.39
4.31
4.23
4.09
3.88
3.87
3.85
3.85
3.79
3.79
3.68
3.62

Numer
1.70
1.88
1.91
2.33
3.11
2.06
2.79
1.89
1.74
3.45
2.04
1.81
1.40
1.33
2.85
1.99
1.54
2.06
1.57
1.12

Denom
0.33
0.38
0.38
0.47
0.64
0.43
0.58
0.42
0.40
0.80
0.48
0.44
0.36
0.35
0.74
0.52
0.41
0.54
0.43
0.31

cont-1
−8.56
−8.09
−7.08
−6.95
−5.17
−7.06
−5.21
−7.40
−5.92
−3.97
−5.61
−5.74
−6.25
−7.48
−4.52
−5.64
−4.85
−4.29
−5.34
−7.60

cont-2
−8.35
−7.76
−8.22
−6.23
−6.01
−6.60
−6.43
−5.65
−7.18
−5.40
−5.52
−5.60
−6.22
−5.59
−4.13
−4.18
−6.38
−5.12
−5.23
−6.28

cont-3
14.18
10.43
10.39
8.81
7.63
9.32
7.42
7.76
9.11
6.00
7.89
7.82
8.98
8.65
5.05
6.39
7.26
6.43
6.70
8.90

cont-4
3.640
7.220
6.550
5.83
4.74
5.80
5.61
7.04
5.32
4.49
4.32
4.690
4.66
5.91
4.800
4.57
5.29
3.980
5.170
6.63

Table 6.3: Output for the top 20 significant genes in the SAM analysis

6.6

Investigate Treatment Effects
The multiclass method produces standardized contrasts that are useful for

determining which treatment groups contribute to large test statistics. The stan51

dardized contrast (uit ) for gene i and treatment t is defined as uit = (x̄it − x̄i )/si ,
where si is defined in Equation 3.3. There are four treatments in the SAM analysis,
therefore, there are four standardized contrasts per gene.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26

Contrast
-1,-1,1,1
0,-1,1,0
0,-1,1,1
-1,0,0,1
0,0,0,-1
0,-1,0,1
-1,0,1,0
-1,-1,1,0
-1,0,1,1
0,0,-1,0
0,-1,0,0
-1,0,0,0
0,0,0,0
-1,-1,0,1
0,0,-1,1
-1,1,0,0
-1,1,0,1
0,-1,1,-1
-1,1,-1,1
-1,0,1,-1
-1,-1,1,-1
-1,0,-1,1
-1,1,-1,0
-1,1,0,-1
-1,1,1,0
0,0,-1,-1

Genes
892
208
149
136
191
95
105
95
110
91
57
32
30
16
12
14
7
3
2
1
1
1
1
0
1
0

Contrast
1,1,-1,-1
0,1,-1,0
0,1,-1,-1
1,0,0,-1
0,0,0,1
0,1,0,-1
1,0,-1,0
1,1,-1,0
1,0,-1,-1
0,0,1,0
0,1,0,0
1,0,0,0
0,0,0,0
1,1,0,-1
0,0,1,-1
1,-1,0,0
1,-1,0,-1
0,1,-1,1
1,-1,1,-1
1,0,-1,1
1,1,-1,1
1,0,1,-1
1,-1,1,0
1,-1,0,1
1,-1,-1,0
0,0,1,1

Genes
481
320
240
150
76
142
105
85
65
73
44
37
30
39
25
11
1
4
1
1
0
0
0
1
0
1

Total
1373
528
389
286
267
237
210
180
175
164
101
69
60
55
37
25
8
7
3
2
1
1
1
1
1
1

Table 6.4: Summary of standardized contrasts for the SAM analysis. The standardized
contrasts represent treatment means that are exceptionally above (+1) or below (−1)
the overall mean. There were 4,152 significant genes.

The standardized contrasts are calculated from the simulated null distribution.
The uit that are greater than the 97.5th percentile in the null distribution are flagged
with +1, whereas the uit that are less than the 2.5th percentile are flagged with −1.
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Figure 6.5: SAM plots for treatment effects.

Finally, if a gene did not have an exceptionally high or low uit then that particular
treatment group was flagged with 0.
The standardized contrasts for the significant genes in the mouse pregnancy
data can be seen in Table 6.4. The largest number of standardized contrasts (1,373)
is associated with comparing the first two treatment groups (LPS:B6 and LPS:KO)
to the last two treatment groups (SAL:B6 and SAL:KO). This suggests that there is
a main effect for the LPS versus the Saline solutions.
The significance of the two main effects and the interaction effects can be
examined in separate SAM analyses. Figure 6.5 shows the SAM plots for three
pairwise SAM analyses. In these analyses, the two-class unpaired method is used.
This method basically employs a two-sample t-test for each gene, and it can be used
to compare two effects at a time.
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The first follow-up SAM analysis shows the difference between the LPS and
Saline solutions. Again, the strong departure from the diagonal line suggests a strong
effect difference between LPS and Saline (TS = 0.62 ± 0.33).
The second follow-up SAM analysis shows the difference between the B6 and
Knock-out groups. There is a departure from the expected values, but it is not nearly
as strong as the analysis for solution (TS = 0.12 ± 0.38).
The third follow-up SAM analysis shows the interaction between the four
treatment groups. In this analysis there appears to be a slight inversion between
observed and expected values. The strong adherence to a diagonal pattern suggests
that there is no interaction between the four treatment groups (TS = −0.22 ± 0.31).
The plots support the conclusion that the solution is driving most of the
significance in the analysis, but the mouse type appears to have some influence also.
There appears to be no interaction effect.
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Chapter 7
Conclusion
The purpose of this project is to compare two popular methods for analyzing
genomic data. This paper considered two methods. The first, a mixed models approach, uses a normalization model followed by a gene model. Genes are declared
significant when their pairwise comparisons for the treatment effect in the gene model
are significant. The second, the Significance Analysis of Microarrays, compares a test
statistic to its expected value, which is estimated with resampling. Genes are declared significant when the difference between the observed the expected test statistic
exceeds a threshold.

7.1

Comparison of Results
The mouse pregnancy data tested 21,529 genes. Table 7.1 compares the results

for the mixed models and SAM analyses. Some genes were not included in the analyses
due to poor or insufficient data. The mixed models analysis did not include 1,727
genes, whereas the SAM analysis did not include 4,179 genes. Of the remaining genes,
the mixed models analysis produced 3,542 genes with at least one pairwise comparison
when the FWER was 5%. The SAM analysis produced 4,152 significant genes when
the FDR was 5%. There were 1,827 genes that were significant in both analyses.
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SAM Procedure
Not Included
Not Significant
Significant
Total

Mixed Models Approach
Not Included Not Significant‡ Significant†
1,722
2,456
1
4
11,480
1,714
1
2,324
1,827
1,727
16,260
3,542

Total
4,179
13,198
4,152
21,529

Table 7.1: Comparison of significant genes. † At least one significant pairwise comparison. ‡ No significant pairwise comparisons.

In general, there was agreement between the two methods. There were 1,827
genes declared significant in both methods, 11,480 genes declared not significant in
both methods, and 1,722 genes that were not analyzed in either method, for a total
agreement of 15,029/21,529 = 68.8%.
The two methods produced different results. In part this was due to the
differences in their methodologies. However, there are several other reasons why
the two analyses did not share more results in common: first, the mixed analysis
used unbalanced data, whereas the SAM analysis used aggregated and imputed data;
second, the mixed analysis assumed normally distributed errors, whereas the the SAM
analysis assumed nothing; third, the mixed analysis used background corrected log2
intensities whereas the SAM analysis used log ratio intensities; fourth, the mixed
analysis used all possible pairwise comparisons to test treatment effects, whereas the
SAM analysis used an overall test for treatment effects; fifth, the mixed analysis used
a mixed model to normalize the data, whereas the SAM analysis used print-tip lowess
smoothers; and sixth, the mixed analysis used data from the reference slide, whereas
the SAM analysis did not.
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The differences between the mixed models approach and the SAM procedure
are confounded with the differences in procedure mentioned in the previous paragraph.
In order to get a better comparison all extraneous factors should be held constant,
allowing the results from the two methods to be more similar; for example, the data
could be normalized only once and applied to the two methods, removing the effect
of the normalization procedure when comparing the two methods. Unfortunately,
some differences cannot be held constant, for example, the SAM procedure cannot
handle unbalanced data and the effect of aggregating and imputing the data will be
confounded with the differences between the two methods whenever unbalanced data
are analyzed.
This project analyzed the mouse pregnancy data with the mixed models approach and the SAM procedure. One important difference between the two analyses
was the two different data types. The mixed models analysis used background corrected log2 intensities, whereas the SAM analysis used log ratio intensities. The
mixed models analysis tested whether the treatments, including the reference, were
the same, while the SAM analysis tested whether the differences between the treatment and the reference were the same; thus, the nature of the two comparisons were
different. If both methods were used to analyze the same type of data, one might
expect to see more similar results.
Another important difference between the two analyses was the way in which
genes were declared significant. In the mixed models analysis, all pairwise comparisons were tested for significance. There were five treatment levels, creating ten
pairwise comparisons associated with each gene. In the SAM procedure only the rel57

ative difference was tested for significance, and there was only one relative difference
associated with each gene; unfortunately, there is no method for testing all pairwise
differences in the SAM procedure, but the mixed models approach can test the overall
effect for each treatment with an F -statistic. If the overall test for treatment in the
mixed models analysis is compared to the relative difference in the SAM analysis, one
might expect to see more similar results.
In a separate analysis, the mouse pregnancy log ratios were analyzed with the
mixed models approach. For each gene the negative log10 p-value from the overall
test for treatment was compared to the relative difference from the SAM analysis.
Negative log10 p-values were used for convenience only. A Bonferroni adjustment was
used to control the FWER in the mixed models analysis. There were 19,466 genes
considered in the mixed models analysis, so the cutoff was − log10 (0.05/19, 466) =
5.59. In the mixed models analysis, the 391 genes with negative log10 p-values greater
than the cutoff were declared significant.
For convenience, the cutoff in the SAM analysis was chosen to produce the
same number of significant genes as the mixed models analysis. This resulted in a
cutoff of 1.46. In the SAM analysis, the 391 genes with a relative difference greater
than 1.46 were declared significant.
Figure 7.1 shows the relationship between the negative log10 p-values from
the mixed analysis and the relative differences from the SAM analysis. There is an
overall agreement between the two methods. The Pearson correlation between the
two variables is 0.82. There appears to be a slight curvature to the scatter. The
curvature could be due to poor normalization in one of the methods. There appears
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Figure 7.1: Negative log10 p-values from the mixed models analysis versus the relative differences from the SAM analysis. The correlation suggests a general agreement
between the two methods.

to be a group of genes that are much more significant in the mixed models analysis
and another group that are much more significant in the SAM analysis. The two
branches in Figure 7.1 indicate that the two methods are systematically treating two
types of genes in different ways. This may be due to the fact that the reference
sample (microarrays 45 − 48) was included in the mixed models analysis but not in
the SAM analysis. One branch in Figure 7.1 may be due to genes that are significantly
different than the reference sample, and the other branch may be due to genes that
are not. Alternatively, the branches could be due to the extra preprocessing in the
SAM analysis. Replicated data from the SAM analysis were averaged and missing
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data were imputed. Perhaps averaging the replicates removed too much information,
or imputing the missing data included the wrong information.
Table 7.2 compares the genes declared significant when the mixed models cutoff
is 5.59 and the SAM cutoff is 1.46. There were 17,345 genes that were included in
both analyses, 391 of which were declared significant. The percent of genes declared
significant in both methods was 205/391 = 52.4%. The models had a (205 + 16,768 +
2,058)/21,529 = 88.4% agreement. The mixed models analysis included 2,121 genes
that the SAM analysis did not; however, none of these extra genes were significant.
By comparison, the SAM analysis only included 5 genes that were not in the mixed
models analysis. These genes were also considered non-significant.

SAM Procedure
Not Included
Not Significant
Significant
Total

Mixed Models Approach
Not Included Not Significant Significant
2,058
2,121
0
5
16,768
186
0
186
205
2,063
19,075
391

Total
4,179
16,959
391
21,529

Table 7.2: Comparison of significant genes when the mixed models cutoff is 5.59 and
the SAM cutoff is 1.46.

The simulated null distribution from the SAM analysis can be used to estimate
p-values from the relative differences. A comparison of p-values can be seen in Figure 7.2. The distributions look very similar for both methods. The small p-values in
the mixed models method taper off more quickly than the SAM p-values, because the
SAM procedure cannot measure extremely small p-values. By definition, the smallest
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Figure 7.2: Distribution of p-values for the mixed models analysis (red) and the SAM
analysis (blue).

p-value in any SAM analysis is 1/n, where n is the total number of genes. In this
analysis, the smallest p-value is 1/17,350 = 5.7637 × 10−5 . By contrast, the smallest
p-value in the mixed models analysis is 1.7079 × 10−26 .
Another way of comparing the results of the two methods is to examine the
percent of shared genes. For example, the 10% most significant genes from the mixed
analysis and the 10% most significant genes from the SAM analysis share 75.2%
of their genes in common. This percentage tends to increase as the percentage of
genes considered increases; for example, the 50% most significant genes from both
methods share 82.2% in common, and all of the genes from both methods share all
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Figure 7.3: Percent of genes shared versus the percent of genes considered.

their genes in common. A plot of the percent of genes shared against the percent of
genes considered in both methods is shown in Figure 7.3.
The percent of genes shared is approximately 78% when the percent of genes
considered is 20%. This means that there is fairly good agreement between the two
methods for the upper 20% of the data. A small dip in the percent of genes shared
occurs from the 20% − 30% range of genes considered. This dip is a result of the
mixed models p-values tapering off more rapidly than the SAM p-values at the lower
tail of the distributions (see Figure 7.2). This chart shows that the methods tend
to have especially strong agreement when at least the top 20% of both gene lists are
considered.
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The results of analyses were more comparable when the log ratios were analyzed and the overall test for treatment from the mixed analysis was compared to
the relative difference from the SAM analysis. The p-values from the mixed models
analysis were highly correlated with the relative differences from the SAM analysis.
There was a 88.4% agreement between the two methods when the FWER was controlled at α = 0.05. The distribution of p-values were very similar. There was a large
percentage of genes shared in the top 20% of the most significant genes from both
methods.
Although the results from both methods are similar it is still unclear whether
the differences are due to the two methods or to some other factors in the two methods,
such as the different normalization techniques; also, the reference sample was used in
the mixed models analysis but not in the SAM analysis. If the same normalization
technique was used for both methods and if the reference sample was eliminated from
both methods, then one would expect the results to become more similar. Using the
same data type and comparing similar statistics made the results of the mixed models
and SAM analyses more similar. It is reasonable to suppose that the more extraneous
factors are controlled, the more similar the results will be.

7.2

Comparison of Methods
The mixed models approach and the SAM procedure have fundamentally sim-

ilar approaches to analyzing microarray data. Table 7.3 lists the critical steps in the
two methods. The first step is to organize and prepare the data for analysis. The
second step is to normalize the data. Normalization removes effects due to the exper63

imental setup rather than effects due to the genes. The third step is to analyze the
data and test for differential gene expression. The fourth step is to finalize the list of
significant genes by employing some cutoff rule. The cutoff is based on an error rate
such as the FWER or the FDR.

1. Organize
2. Normalize
3. Analyze

4. Finalize

Mixed Models Approach
Clean the data.
Use one mixed normalization model for all genes.
Use a separate mixed gene
model for each gene.
Identify significant pairwise
comparisons.

SAM
Clean, aggregate, and impute the data.
Choose any method.
Calculate the relative difference and estimate its null
distribution.
Compare the observed versus the expected statistics.

Table 7.3: Overview of the mixed models approach and the SAM procedure.

The mixed models approach and the Significance Analysis of Microarrays are
two methods for identifying differential gene expression. Determining which method
to use depends on the advantages and disadvantages of the two methods. Each has
certain characteristics that are inherent and cannot be changed; for example, the
mixed models approach uses parametric models to analyze the data, whereas the
SAM procedure uses random permutations of the data to simulate the null distribution. Each method also has characteristics that are flexible and can be changed; for
example, model specification in the mixed models approach and normalization in the
SAM procedure depend entirely on the researcher’s discretion. The following sections
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will identify inherent and flexible characteristics as well as comment on some of the
advantages and disadvantages of both methods.

7.2.1

Inherent Characteristics of the Mixed Models Approach
The mixed models approach has at least four inherent advantages. The first

advantage is that the mixed models approach tolerates unbalanced data. Microarray data can be unbalanced for a variety of reasons; for example, measurements can
be thrown out due to negative expression or poor quality, or measurements may be
replicated unequally. The mixed models approach tolerates unbalanced data. The
only requirement for applying the mixed models approach to unbalanced data is that
there be enough degrees of freedom to estimate error terms. The capability of analyzing unbalanced data allows the mixed models approach to take advantage of every
observation in the data set. It allows the mixed models approach to estimate more
genes and more treatment effects. It also allows the precision of variance estimates
to be proportional to the amount of data available.
The second inherent advantage of the mixed models approach is the assumption of a heterogeneous error structure. In the mixed models approach, a separate
gene model is fit to every gene; thus, every gene has its own set of variance estimates.
This is reasonable given the wide variety of gene expression. One advantage of heterogeneous variances is that it produces better specified models. Another advantage
is that estimates of the variance terms may be of interest in their own right.
A third inherent advantage of the mixed models approach is flexible model
specification. The normalization and gene models can be adapted to a wide variety of
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experimental designs. Better model specification can lead to increased precision of the
treatment effects. Additionally, non-treatment effects can be tested for significance.
A fourth inherent advantage of the mixed models approach is the ability to
estimate pairwise comparisons of the treatment effect. The mixed models approach
can not only test for an overall treatment effect, it can also test for pairwise treatment effects. The ability to test pairwise treatment effects allows the mixed models
approach to identify exactly which treatments are causing significant gene expression.
The mixed models approach has at least one inherent disadvantage. The
normalization and gene models both assume independent, normally distributed errors.
Numerous studies show that gene expression is not independent between genes. Genes
tend to be correlated due to the genetic pathways they depend on. Furthermore, the
error structure of many microarray studies is not normal. Assuming normality may
lead to a misspecified model and improper conclusions regarding treatment effects.

7.2.2

Inherent Characteristics of the SAM Procedure
The SAM procedure has at least two inherent advantages. First, the SAM

procedure makes no distributional assumptions. The distribution of expected order
statistics is estimated with resampling. There are no assumptions to validate, and
there is little risk that the expected null distribution is much different than the true
null distribution. Because the SAM procedure makes no distributional assumptions,
it can be used on a larger group of microarray analyses, including those with irregular
distributions.
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A second inherent advantage of the SAM procedure is flexible specification
of the relative difference. For two-class data the relative difference is essentially a
t-statistic. For multiclass data the relative difference is essentially an F -statistic,
but the relative difference could be specified in any form; for example, it can be
defined to identify genes whose expression correlates with survival time or some other
quantitative measure. Allowing the relative difference to be specified in any form
allows the SAM procedure to be adapted to a broad range of experiments.
The SAM procedure has at least two inherent disadvantages; first, the SAM
procedure does not handle unbalanced data. Instead, it requires the data to be
arranged in a p×n array were p is the number of genes and n is the number of samples,
forcing the data to have exactly one gene expression for each sample. This means that
preprocessing is often arduous for complex experimental setups. It also means that
unbalanced data typically have to be aggregated, removed, or imputed. For example,
the mouse pregnancy data had an unequal replication of spots in each each of the 16
samples. Some genes were replicated twice while others were replicated four times,
so the replicates in the mouse pregnancy data were averaged across each sample.
The mouse pregnancy data also contained a large number of missing values due to
negative or poor quality gene expression. Genes without at least one expression value
in each treatment group were thrown out. This rule eliminated 20% of the genes.
Aggregating the data into a p × n array also forced the SAM analysis to exclude
the reference sample. In order for the reference sample to have been included, it
would have needed to be replicated. Missing values in the remaining genes were
imputed using a K-nearest neighbor algorithm. The fact that some measurements
67

represented the average of four replicates while others represented the average of
two replicates while still others represented imputed values did not factor into the
analysis. The SAM procedure treats all measurement with the same precision. The
researcher is forced to assume that the aggregated data is as accurate as the imputed
data. Furthermore, the researcher is forced to decide how much missing data can
be reliably imputed. Aggregating data removes information, whereas imputing data
creates information. The SAM procedure has no way to measure the effect that
imputing and aggregating has on an analysis.
A second inherent disadvantage of the SAM procedure is the lack of pairwise
comparisons. The SAM procedure produces one statistic per gene. For multiclass
data the statistic is essentially an F -value; therefore, the statistic tests whether there
is a difference in at least one treatment group. If there is a difference then it is
natural to investigate which group or groups cause the difference. The SAM procedure does not test pairwise comparisons. Instead it provides standardized contrasts
that indicate which treatments are different; however, standardized contrasts are not
statistical tests, they merely aid in identifying which treatment group or groups are
different. The lack of pairwise comparisons in the SAM procedure makes identifying treatment effects difficult. It also makes identifying genes with highly significant
pairwise comparisons difficult.

7.2.3

Flexible Characteristics of Both Methods
There are a number of flexible characteristics associated with both analysis

methods. The first is that both methods can analyze various types of data. The
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mixed models analysis used background corrected log2 gene intensities. The SAM
analysis used log ratios. Both methods can be used to estimate either type of data. If
the mixed models approach is used to analyze log ratio data, the model specification
will need to change and a covariate for the log average, A, should be included. If the
SAM procedure is used to analyze background corrected log2 data, the p × n data
array will appear very differently. There will still be p rows, but n will be twice as
large in order to accommodate two measurements per gene spot.
The type of data analyzed depends on the type of hypothesis desired. In twochannel data, each gene spot is exposed to a treatment and a reference, so there are
two measurements per gene spot. If the background corrected log2 data are analyzed,
then the reference is considered to be another treatment. If the log ratios are analyzed, then each treatment is compared to its corresponding reference. The treatment
effects for the background corrected log2 data are the effect of each treatment, including the reference treatment, on the response. The treatment effects for the log
ratio data are the differences between the treatment and its corresponding reference.
The null hypothesis for background corrected log2 data is that the treatment effects,
including the reference, are the same. The null hypothesis for log ratio data is that
the differences between the treatment and the reference are the same.
The treatment effects associated with background corrected log2 data are inherently different than the treatment effects associated with log ratio data. Any
statistical test for treatment is also inherently different for the two types of data.
One would expect to get different results by analyzing each type of data. The type
of data analyzed depends on the type of hypothesis desired.
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A second characteristic that is flexible for both methods is specifying the normalization technique. In the mixed models approach, data are normalized with a
mixed model, but the data could technically be normalized using any number of
techniques; for example, the mouse pregnancy data showed large variability between
print-tip groups, so the data could have been normalized with a different mixed model
for each print-tip group. In the SAM procedure no normalization technique is specified. The normalization procedure depends entirely on the discretion of the researcher.
The mouse pregnancy data were normalized with lowess smoothers; however, the data
could have been normalized with a mixed model. Specifying the normalization technique allows researchers to choose the best technique for their data.
A third characteristic that is flexible for both methods is measuring error rates
and quantifying genome-wide summary measures. The mixed models approach provides strong control of the family-wise error rate. The SAM procedure, on the other
hand, provides weak control of the FDR. However, the FWER or the FDR could be
estimated in either method. The mixed models approach could use several techniques
for estimating the FDR from p-values, while the SAM procedure can estimate p-values
based off of the simulated null distribution. The SAM procedure also produces estimates of a Type II error rate called the Miss Rate and a genome-wide summary
measure called the Tail Strength. The mixed models approach does not currently estimate the Type II error rate or genome-wide summary measures, but methods could
be developed to estimate them. Measuring error rates and quantifying genome-wide
summary measures allow researchers to assess significance and compare studies.
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7.3

Comparison of Software
The mixed models approach depends on the SASr Mixed Procedure. SASr

handles data sets such as the mouse pregnancy data very efficiently. Specifying the
model structure in the mixed procedure is also very easy, but specifying complex models in the mixed models approach can prove to be problematic and time consuming.
Because the normalization model is applied to the entire data set, it is computationally advantageous to use a simplistic model. Specifying a very complex normalization
model can take days to run: it took three days to normalize the mouse pregnancy
data when a print-tip effect was included, but only 10 minutes without it. Gene
models also benefit from a simplistic design. Since every gene has its own model, a
complex specification increases computation time. Convergence criteria are also less
likely to be met, and complex models are more likely to include insignificant terms.
While the mixed model approach may technically permit any valid specification of
the normalization model, a simple model specification provides the quickest results
with the least amount of problems. Even with a simplistic model, the mixed models
analysis of the mouse pregnancy data experienced problems running on a personal
computer, so the mouse pregnancy data were analyzed with an AIX Unix server.
The total run time, including reading the data, normalizing it, and running the SAM
analysis, was approximately 35 minutes.
The SAM procedure depends on R, an open source environment for statistical computing and graphics. The actual code for the the SAM procedure is part
of the samr package. This package is available royalty-free to academic users. The
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samr package can be run through a Microsoft Excelr interface or directly through
the R interface. If it is run through R, then the error handler should be deactivated
with the following command: options(error=NULL). Neither R nor Excelr handles
exceptionally large data sets very well. Data in Excelr is limited to the maximum
spreadsheet size. Data in R is limited to the amount of available RAM. The specification of the relative difference cannot be modified in the samr package. The user is
restricted to one of ten options. The R environment includes a number of tools that
are useful for visualizing, normalizing, and analyzing microarray data. The mouse
pregnancy data were normalized with a technique used in the Bioconductor software,
a suite of packages designed for the analysis of genomic data. The mouse pregnancy
data were analyzed with a Microsoft Windows personal computer running an Intel
Pentium 4 processor at 3.0GHz. The total run-time, including reading the data,
normalizing it, and running the SAM analysis, was approximately 13 minutes.

7.4

Suggestions for Future Research
This project revealed several areas for future research. The normality assump-

tion in the mixed models approach could be investigated. Wolfinger et al. (2001) suggests that the method will serve analysts well in the large majority of cases. However,
it is unclear how robust the mixed models approach is.
A more exact comparison between the mixed models approach and the SAM
procedure could be investigated. The mouse pregnancy data came from a fairly
complex experimental setup. The results of the two analyses were confounded with
many factors besides the two methodologies. If a simple data set were chosen and
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analyzed, it could provide a more exact comparison. The data set would preferably
be balanced with no missing data.
The effect of normalization could be investigated. There have been numerous
normalization techniques proposed, but their impact on the mixed models approach
and the SAM procedure is unclear. Comparing multiple analyses from different normalization techniques could reveal the effect that normalization has on the results.
The treatment effects could also be investigated. Neither method makes identifying treatment effects easy. Both methods force the user to investigate treatment
effects at the gene level. In the mouse pregnancy data, it was found that the labor inducing solution, LPS, caused the vast majority of significant differences. This
conclusion was reached only after a superficial examination of the results. Future
research could be conducted into quantifying and comparing overall treatment effects
on an experiment.
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Appendix A
Technical details of the SAM procedure
The data is xij , i = 1, 2, . . . , p genes, j = 1, 2, . . . , n samples, and response
data yj , j = 1, 2, . . . , n (yi may be a vector).
A.1

SAM procedure

1. Compute a statistic
di =

ri
; i = 1, 2, . . . p
si + s0

(A.1)

ri is a score, si is a standard deviation, and s0 is a fudge factor. Details of these
quantities are given in A.2 and A.3.
2. Compute order statistics d(1) ≤ d(2) · · · ≤ d(p) .
3. Take B sets of permutations of the response values yj . For each permutation b
∗b
∗b
compute statistics d∗b
(1) ≤ d(2) · · · ≤ d(3) .

4. From the set of B permutations, estimate the expected order statistics by d¯(i) =
P
(1/B) b d∗b
(i) for i = 1, 2, . . . , p.
5. Plot the d(i) values versus the d¯(i) .
6. For a fixed threshold ∆, starting at the origin and moving up to the right, find
the first i = i1 such that d(i) − d¯(i) > ∆. All genes past i1 are called significant
positive. Similarly, start at origin, move down to the left and find the first
i = i2 such that d(i) − d¯(i) > ∆. All genes past i2 are called significant negative.
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For each ∆ define the upper cut-point cutup (∆) as the smallest di among the
significant positive genes and similarly define the lower cut-point cutlow (∆).
7. For a grid of ∆ values, compute the total number of significant genes (from the
previous step), and the median number of falsely-called genes, by computing
the median number of values among each of the B sets of d∗b
(i) , i = 1, 2, . . . , p
that fall above cutup (∆) or below cutlow (∆). Repeat this process for the 90th
percentile of falsely called genes.
8. Estimate π0 , the proportion of true null (unaffected) genes in the data set, as
follows.
(a) Compute q25, q75 = 25% and 75% points of the permuted d values (if
p = # genes, B = # permutations, there are pB such d values).
(b) Compute π̂0 = #{di ∈ (q25, q75)}/(0.5p) (the di are the values for the
original data set: there are p such values.)
(c) Let π̂0 = min(π̂, 1) (i.e., truncate at 1). This estimate of π0 is analogous to
setting λ = 0.5 in the π̂0 proposed in Storey (2002). For multiclass data,
the scores are all positive, so we use the 0th and 50th percentiles of the
permuted values [NOTE: this was corrected in version 2.0].
9. The median and 90th percentile of the number of falsely-called genes from step
6, are multiplied by π̂0 .
10. User then picks a ∆ and the significant genes are listed.
11. The False Discovery Rate (FDR) is computed as median (or 90th percentile)
of the number of falsely called genes divided by the number of genes called
significant.
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12. Fold Change. Suppose x̄i1 and x̄i2 are the average expression levels of a gene i
under each of two conditions. These averages refer to raw (not logged) data. If
a nonzero fold change t is also specified, then a positive gene must also satisfy
|x̄i1 /x̄i2 | ≥ t in order to be called significant and a negative gene must also
satisfy |x̄i1 /x̄i2 | ≤ 1/t to be called significant. When a fold change is specified,
genes with either x̄i1 ≤ 0 or x̄i2 ≤ 0 (or both) are automatically left off of the
significant gene list, as their fold change cannot be unambiguously determined.
When such fold changes are reported in output, they are indicated by NA.
13. The local FDR for a gene is the false discovery rate for genes having a similar
relative difference di as that gene. It is estimated by taking a symmetric window
of 0.5% of the genes on each side of the target gene, and estimating the FDR
in that window. If 1.0% times the total number of genes in the data set is less
than 50, then the percentage is increased so that the number of genes is 50.
A.2

Computation of s0

1. Let sα be the α percentile of the si values. Let dαi =

ri
.
si +sα

2. Compute the 100 quantiles of the si values, denoted by q1 ≤ q2 ≤ . . . ≤ q100 .
3. For α ∈ (0, 0.05, 0.10 . . . 1.0)
(a) Compute vj = mad(dαi | si ∈ [qj , qj+1 )), j = 1, 2, . . . n, where mad is the
median absolute deviation from the median, divided by 0.64.
(b) Compute cv(α) = Coefficient of variation of the vj values.
4. Choose α̂ = argmin[cv(α)]. Finally compute ŝ0 = sα̂ . s0 is henceforth fixed at
the value of ŝ0 .

77

A.3

Details of ri and si for different response types.

1. Two class, unpaired data yj = 1 or 2. Let Ck = {j : yj = k} for k = 1, 2.
P
P
Let nk = # in Ck . Let x̄ij = j∈C1 xij /n1 , x̄i2 = j∈C2 xij /n2 .
ri = x̄i2 − x̄i1
s
P
P
2
2
1
1
j∈C1 (xij − x̄i1 ) +
j∈C2 (xij − x̄i2 )
si =
( + )
n1 n2
(n1 + n2 − 2)

(A.2)
(A.3)

2. Multiclass response yi ∈ {1, 2, . . . K}. Let Ck = indices of observations in
P
P
class k, nk = # in Ck , x̄ik = j∈Ck xij /nk , x̄i = j xij /n.
sP

nk X
nk [x̄ik − x̄i ]2
n
k k k
v P
u
1
XX
u
k nk
= tP
[xij − x̄ik ]2
k (nk − 1) k j∈C

ri =

si

Qk

k
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(A.4)

(A.5)

Appendix B
Mixed Models Code
/* ------------------ Input Macro ---------------------- */
%macro readdata;
/* Input Gene Names */
data keys;
infile "Key.csv" expandtabs;
input Name Gene;
run;
%do i=1 %to 48;
/* Input Green Channel */
Data green;
infile "Green.txt" expandtabs;
input G Gb GFlag;
run;
/* Input Red Channel */
Data red;
infile "Red.txt" expandtabs;
input R Rb RFlag;
run;
/* Merge Data */
data arrayi;
merge green red keys;
array=&i;
spot=_n_;
if (rflag=0 and gflag=0) then do;
dye="Green";
diff=G-Gb;
if(diff > 0) then logi = log2(diff);
else logi = .;
output;
dye="Red";
diff=R-Rb;
if(diff > 0) then logi = log2(diff);
else logi= .;
output;
end;
keep array gene name spot dye logi;
run;
proc append base=arrayall data=arrayi;
run;
%end;
%mend;
/* Create Treatment Variable */

79

data preg;
set arrayall;
format strain $6.;
set preg;
if dye=’Red’ then do;
else do;
if array<=12 then
else if array<=24
else if array<=39
else if array<=45
else if array<=48
end;
run;

strain="Ref"; end;
do; strain="B6:LPS"; end;
then do; strain="KO:LPS"; end;
then do; strain="B6:Sal"; end;
then do; strain="KO:Sal"; end;
then do; strain="Ref"; end;

/* ------------------ Normalization Model ---------------------- */
/* Normalize Data */
proc mixed data=preg covtest cl lognote;
class array strain;
model logi = strain / outp=pregnorm;
random array strain*array;
lsmeans strain / diff cl;
run;
/* ------------------ Gene Model ---------------------- */
/* Delete NA Genes */
data pregnorm;
set pregnorm;
if gene=’’ then delete;
run;
/* Sort For Gene Models */
proc sort data=pregnorm;
by gene array spot;
run;
/* Individual Gene Models */
ods listing close; run;
proc mixed data=pregnorm;
by gene;
class array spot dye strain;
model resid = strain;
random array spot(array);
lsmeans strain / diff;
ods output tests3=overall diffs=pairwise convergencestatus=conver;
run;
ods listing; run;
/* ------------------ Significant Genes ---------------------- */
/* Significant Pairwise Tests */
data pairwisesig;
set pairwise;
log10p = -log10(probf);
if log10p > -log10(0.05/194480);
run;
/* Summary Table of Significant Pairwise Tests */
proc freq data=pairwisesig;
tables _strain*strain;
run;
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Appendix C
SAM Code
###########################################################################
### Input Data
###########################################################################
### Gene Names
gnameA<-read.csv(paste(dir3,’Mouse Slide A Key.csv’,sep=’’))$GB
gnameB<-read.csv(paste(dir3,’Mouse Slide B Key.csv’,sep=’’))$GB
gnameC<-read.csv(paste(dir3,’Mouse Slide C Key.csv’,sep=’’))$GB
glong<-c(as.character(gnameA),as.character(gnameB),as.character(gnameC))
gshrt<-unique(glong)[-1]
### Mouse Grid
mgrid<-list(
A=list(nspot.r=20,nspot.c=20,ngrid.r=12,ngrid.c=4),
B=list(nspot.r=20,nspot.c=20,ngrid.r=12,ngrid.c=4),
C=list(nspot.r=16,nspot.c=21,ngrid.r=12,ngrid.c=4))
msize<-lapply(lapply(mgrid,unlist),prod)
### Setup Empty Mouse Data
matA<-matrix(0,19200,16)
matB<-matrix(0,19200,16)
matC<-matrix(0,16128,16)
mouse<-list(
A=list(R=matA,G=matA,Rb=matA,Gb=matA,flag=matA),
B=list(R=matB,G=matB,Rb=matB,Gb=matB,flag=matB),
C=list(R=matC,G=matC,Rb=matC,Gb=matC,flag=matC))
### Read Mouse Data
for(i in 1:3){
for(j in 1:16){
grn<-read.table(’grnpath’,header=T,sep=’\t’,skip=42,nrows=msize[[i]])
red<-read.table(’redpath’,header=T,sep=’\t’,skip=42,nrows=msize[[i]])
mouse[[i]]$R[,j]<-red$Signal.Mean
mouse[[i]]$G[,j]<-grn$Signal.Mean
mouse[[i]]$Rb[,j]<-red$Background.Mean
mouse[[i]]$Gb[,j]<-grn$Background.Mean
if(!identical(red$Flag,grn$Flag)) stop(’Flags not identical’)
mouse[[i]]$flag[,j]<-red$Flag
}
}
###########################################################################
### Normalize Data
###########################################################################
### Remove Flags
mdat<-list(A=mouse$A[1:4],B=mouse$B[1:4],C=mouse$C[1:4])
for(i in 1:3) for(j in 1:4) mdat[[i]][[j]][mouse[[i]][[5]]!=0]<-NA
### Normalize Within Arrays
MA.pts<-list()
MA.pts$A<-stat.ma(mdat$A,mgrid$A,norm=’p’)
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MA.pts$B<-stat.ma(mdat$B,mgrid$B,norm=’p’)
MA.pts$C<-stat.ma(mdat$C,mgrid$C,norm=’p’)
for(i in 1:3) for(j in 1:2) colnames(MA.pts[[i]][[j]])<-paste(’S’,1:16,sep=’’)
### Normalize Between Arrays
MA.lall<-list(A=alist(A=,M=),B=alist(A=,M=),C=alist(A=,M=))
for(i in 1:3) MA.lall[[i]][[’A’]]<-stat.norm.exp(MA.pts[[i]][[’A’]])
for(i in 1:3) MA.lall[[i]][[’M’]]<-stat.norm.exp(MA.pts[[i]][[’M’]])
MA.all<-list()
MA.all$A<-stat.norm.exp(rbind(MA.lall$A$A,MA.lall$B$A,MA.lall$C$A))
MA.all$M<-stat.norm.exp(rbind(MA.lall$A$M,MA.lall$B$M,MA.lall$C$M))
for(i in 1:2) rownames(MA.all[[i]])<-glong
### Aggregate
MM.lagg<-apply(MA.all$M,2,function(x) aggregate(x,list(glong),mean,na.rm=T))
for(i in 1:16) print(sum(gshrt!=as.character(MM.lagg[[i]][[1]])))
MM.agg<-matrix(0,21529,16,dimnames=list(gshrt,names(MM.lagg)))
for(i in 1:16) MM.agg[,i]<-MM.lagg[[i]][[2]]
mean(is.na(MM.agg)) # 19.9% of the genes are NA
mean(apply(is.na(MM.agg),1,any)) # 39.9% of the genes have at least one NA
### Reduce
grps<-c(1,1,1,1,2,2,2,2,3,3,3,3,4,4,4,NA)
grplabs<-c(’LPS&B6’,’LPS&KO’,’SAL&B6’,’SAL&KO’)
grpcnt<-matrix(0,21529,4,dimnames=list(gshrt,grplabs))
for(i in 1:4) grpcnt[,i]<-rowSums(!is.na(MM.agg[,grps==i]))
grpidx<-apply(grpcnt>=1,1,all)
MM.red<-MM.agg[grpidx,]
### Impute Missing Values
MM<-impute.knn(MM.red,k=15,rowmax=0.75,maxp=nrow(MM.red))
###########################################################################
### SAM Analysis
###########################################################################
### Data Prep
mat1<-MM[,1:15]
tmt1<-c(1,1,1,1,2,2,2,2,3,3,3,3,4,4,4)
gid1<-rownames(mat1)
gnm1<-paste(’g’,gid1,sep=’’)
### SAM Analysis
dat1<-list(x=mat1,y=tmt1,geneid=gid1,genenames=gnm1,logged2=T)
sam1<-samr(dat1,resp.type=’Multiclass’,random.seed=2528)
### False Discovery Rate
fdr1<-samr.compute.delta.table(sam1,dels=seq(0,0.8,by=0.1))
del1<-0.22
cut1<-samr.compute.delta.table(sam1,dels=del1)
### Compute Significant Genes
sig1<-samr.compute.siggenes.table(sam1,del1,dat1,fdr1)
### SAM plot
samr.plot(sam1,del1)
### Miss Rate
mis1<-samr.missrate(sam1,del1,cut1)
### Tail Strength
ets1<-samr.tail.strength(sam1)
### Simulated P-values
pva1<-samr.pvalues.from.perms(sam1$tt,sam1$ttstar)
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